Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Australian tech leading new digital biosecurity infrastructure 2024-07-31 11:32
Connext Successfully Administers First Dose of CNT201 for Dupuytren's Contracture 2024-07-30 21:00
Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia 2024-07-29 23:18
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™ 2024-07-29 22:30
MGI and HKBU Collaborate on Advanced Sequencing Technology to Combat Doping in Sports 2024-07-26 19:35
Innovent and WeComput Announce Strategic Partnership to Advance AI-Driven Drug Discovery and Development 2024-07-26 09:33
Angel Yeast Showcases Innovative Yeast Protein Solutions at Growth Asia 2024 2024-07-26 01:20
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent 2024-07-24 08:10
Telix Successfully Prices A$650 Million Convertible Bonds 2024-07-24 07:51
Telix Announces A$600 Million Convertible Bonds Offering 2024-07-23 16:35
SND Introduces Revolutionary Moderated Drinking Treatment Program 2024-07-23 16:29
QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs 2024-07-23 08:00
DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease 2024-07-23 08:00
Nature Study Reveals: AI and Molecular Dynamics Designed BGM0504 Exhibits Superior Potency 2024-07-22 19:48
Gan & Lee Pharmaceuticals' Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial 2024-07-22 19:00
Join Hands for a Brighter Future!2024 Tianjin Binhai New Area Innovation and Entrepreneurship Competition Overseas Event (Hong Kong SAR Division) Concluded Successfully 2024-07-22 16:41
Duke-NUS launches LIVE Ventures, a S$20 million incubator to accelerate research commercialisation 2024-07-22 10:00
Agilent Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit 2024-07-22 09:12
Everest Medicines Announces First Chinese Patient Dosed in Global Phase 2b PALIZADE Trial of Zetomipzomib in Lupus Nephritis 2024-07-22 09:00
Innovent Announces the Second Phase 3 Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA 2024-07-22 08:00
1 13 14 15 16 17 234